NEUP — Neuphoria Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Neuphoria Therapeutics, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	R2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	10-K	10-K	10-K	10-K
Standards:	IFRS	USG	USG	USG	USG
Status:	fx Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	23.2	12.1	12.6	14.2	19.9
Net Total Accounts Receivable
Net Total Receivables	4.68	0.426	0.127	0.012	0.813
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28.9	13.3	13.2	15	21.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.465	0.333	0.219	0.105	0
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	45.1	28.6	27.6	28.6	28.7
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.32	2.74	3.83	4.22	0.757
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	5.79	6.55	10.2	9.59	4.11
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	39.3	22	17.5	19	24.6
Total Liabilities & Shareholders' Equity	45.1	28.6	27.6	28.6	28.7
Total Common Shares Outstanding